-
Diabetic Peripheral Neuropathy Disease - Global Clinical Trials Review, H2, 2020
Published: December, 2020 - Pages: 188 - US$ 2,500.00
COVID-19 update included[CovidUpdated]
-
Diabetic Peripheral Neuropathy Global Clinical Trials Review, H1, 2020
Published: June, 2020 - Pages: 182 - US$ 2,500.00
COVID-19 update included[CovidUpdated]
-
Non-Proliferative Diabetic Retinopathy (NPDR) Disease - Global Clinical Trials Review, H2 2020
Published: October, 2020 - Pages: 94 - US$ 2,500.00
COVID-19 update included[CovidUpdated]
-
Diabetic Foot Infection (DFI) Disease - Global Clinical Trials Review, H2, 2020
Published: November, 2020 - Pages: 93 - US$ 2,500.00
COVID-19 update included[CovidUpdated]
-
Clinical Trial Management System Market - Global Forecasts to 2025
Published: January, 2021 - Pages: 147 - US$ 4,950.00
COVID-19 update included[CovidUpdated]
-
Global Cancer Biological Toxins Drug Market Opportunity, Drug Sales & Clinical Trials Insight 2026
Published: February, 2021 - Pages: 330 - US$ 2,400.00
COVID-19 update included[CovidUpdated]
-
Global BiTE Antibodies Market , Price, Sales & Clinical Trials Insight 2025
Published: February, 2021 - Pages: 100 - US$ 2,000.00
COVID-19 update included[CovidUpdated]
-
Cervical Intraepithelial Neoplasia (CIN) Disease - Global Clinical Trials Review, H1, 2021
Published: February, 2021 - Pages: 139 - US$ 2,500.00
COVID-19 update included[CovidUpdated]
-
Ewing Sarcoma Disease - Global Clinical Trials Review, H1, 2021
Published: February, 2021 - Pages: 267 - US$ 2,500.00
COVID-19 update included[CovidUpdated]
-
Gonorrhea Disease - Global Clinical Trials Review, H1, 2021
Published: February, 2021 - Pages: 150 - US$ 2,500.00
COVID-19 update included[CovidUpdated]
Would you like sample pages of this report?
US $
Euro €
GBP £